2-Methoxybenzonitrile | CAS:6609-56-9

We serve 2-Methoxybenzonitrile CAS:6609-56-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Methoxybenzonitrile

Chemical Name:2-Methoxybenzonitrile
CAS.NO:6609-56-9
Synonyms:2-Methoxybenzonitrile
1-cyano-2-methoxybenzene
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 255.5±0.0 °C at 760 mmHg
Melting Point 24.5ºC
Molecular Formula C8H7NO
Molecular Weight 133.147
Flash Point 103.4±13.7 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.527
 
Specification:
Appearance:Colorless to light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 2-Methoxybenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-cyano-2-methoxybenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methoxybenzonitrile Use and application,2-Methoxybenzonitrile technical grade,usp/ep/jp grade.


Related News: The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.3-Fluoro-5-methylbenzoic acid manufacturer The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.2-(Dimethylamino)thioacetamide hydrochloride supplier Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.3-[di(propan-2-yl)amino]propan-1-ol vendor Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.